Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Nonpeptide agent · Nonpeptide small molecule
Detailed molecular class: Nonpeptide agent; see mechanism for subtype
Supplied sequence or chemical reference
PubChem CID: 305
Molecular formula: C5H14NO+
IUPAC: 2-hydroxyethyl(trimethyl)azanium
Source: PC-CHOLINE
Database chemical reference; does not certify supplier vial, salt, isomer or formulation.
Mechanism
Nutrient precursor of phospholipids/acetylcholine; not a peptide or inherently a lipolytic drug.
Evidence and critical reading
Reported scientific and empirical uses
Replacement and nutritional context
Nutrition/deficiency prevention; MIC’s attributed hepatic/lipotropic effects require formulation-specific clinical proof.
Human evidence
Deficiency can affect liver/muscle. That physiological need does not establish injectable-blend slimming or cognition benefits in replete people.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
Deficiency can affect liver/muscle. That physiological need does not establish injectable-blend slimming or cognition benefits in replete people.
Deficiency can affect liver/muscle. That physiological need does not establish injectable-blend slimming or cognition benefits in replete people.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.
Adverse effects and unknowns
Excess intake can cause body odor, vomiting and hypotension per institutional review; dietary limits cannot be extrapolated to injection.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Choline · 381 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07450664 · Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeRegistry status: Enrolling by invitationLast update posted: October 14, 2026Query verification: October 16, 2026
NCT05532020 · An Open-Label Study of Diazoxide Choline in Patients With Genetic ObesitiesRegistry status: WithdrawnLast update posted: October 13, 2026Query verification: October 16, 2026
NCT05701774 · Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeRegistry status: CompletedLast update posted: October 13, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- ODS-CHOLINE
October 16, 2026
- PC-CHOLINE
October 16, 2026
- SEARCH-PUBMED-choline
PubMed/MED targeted search: TITLE_ABS:choline AND TITLE_ABS:deficiency AND TITLE_ABS:human
October 16, 2026